Journal
FASEB JOURNAL
Volume 30, Issue 3, Pages 1144-1154Publisher
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.15-277798
Keywords
adrenergic receptor; GPCR; metastasis; stress
Categories
Funding
- National Health and Medical Research Council R. D. Wright Fellowship (Canberra, ACT, Australia) [1061687]
- Drug Discovery Biology Theme Strategic grant
- Australian National Health and Medical Research Council [1008865]
- U.S. National Institutes of Health/National Cancer Institute [CA160890]
- National Breast Cancer Foundation [ECR-11-11]
- National Health and Medical Research Council of Australia [1061687] Funding Source: NHMRC
Ask authors/readers for more resources
Activation of the sympathetic nervous system by stress increases breast cancer metastasis in vivo. Preclinical studies suggest that stress activates beta-adrenoceptors (beta ARs) to enhance metastasis from primary tumors and that beta-blockers may be protective in breast cancer. However, the subtype of beta AR that mediates this effect, as well as the signaling mechanisms underlying increased tumor cell dissemination, remain unclear. We show that the beta(2)AR is the only functionally relevant beta AR subtype in the highly metastatic human breast cancer cell line MDA-MB-231HM. beta(2)AR activation results in elevated cAMP (formoterol pEC(50) 9.86 +/- 0.32), increased intracellular Ca2+ (formoterol pEC(50) 8.20 +/- 0.33) and reduced phosphorylated ERK (pERK; formoterol pIC(50) 11.62 +/- 0.31). We demonstrate that a highly amplified positive feedforward loop between the cAMP and Ca2+ pathways is responsible for efficient inhibition of basal pERK. Importantly, activation of the beta(2)AR increased invasion (formoterol area under the curve [AUC] relative to vehicle: 1.82 +/- 0.36), which was dependent on the cAMP/Ca2+ loop (formoterol AUC in the presence of 2'5'-dideoxyadenosine 0.64 +/- 0.03, or BAPTA-AM 0.45 +/- 0.23) but independent of inhibition of basal pERK1/2 (vehicle AUC with U0126 0.60 +/- 0.30). Specifically targeting the positive feedforward cAMP/Ca2+ loop may be beneficial for the development of therapeutics to slow disease progression in patients with breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available